Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Top Pharma and Biotech firms Trust CompacT Automated Cell Culture to Generate their Cell Lines

Published: Friday, January 11, 2013
Last Updated: Friday, January 11, 2013
Bookmark and Share
See the System at SLAS on TAP Biosystems’ Booth #712 to find out why.

TAP Biosystems announced that with its latest installation of CompacT SelecT™, the technology remains the most widely adopted system for automated culture of adherent cell lines in T-flasks, used by major pharmaceutical and biotech companies worldwide. On Booth #712 at the Society for Laboratory Automation and Screening (SLAS) 2013 there is a unique opportunity to see the CompacT SelecT in action.

The CompacT SelecT systems installed in these leading companies offer parallel, aseptic cell culture processing in T75 and T175 flasks at any time of day or night, without scientists having to be present, thus providing a continuous supply of consistent quality cells for use in cell-based screening programmes.

The systems sited have each been tailored with a range of options which allow tasks such as automated cell imaging and analysis, control of culture conditions, media additions and passaging of immortalised, primary cells or stem cells. The cells are being used in applications including high throughput screening, lead optimisation, assay development, target identification and validation, as well as toxicity studies. The stem cell lines are being utilised to support research in therapeutic areas such as oncology and neurology.

The CompacT SelecT system will be on Booth #712 at SLAS2013. To book a demonstration time and find out more about the system options from TAP’s cell culture experts, please contact Matt Walker by email on matthew.walker@tapbiosystems.com.

Dr Dave Thomas, Product Manager at TAP Biosystems stated: "With the number of automated cell culture technologies increasing, we are pleased that our CompacT SelecT system has become the system of choice in the top pharma and biotech companies. Many of these firms now have multiple systems installed at their North American and European sites and a number are looking to place them in their new Asian drug discovery facilities.”

Thomas added: "The adoption of the CompacT SelecT systems by these leading companies is an excellent endorsement that the technology’s performance capabilities perfectly match their rigorous cell culture demands. Any pharma or biotech scientists looking for a proven and trusted method of consistently generating high quality cell lines should visit us on Booth #712 at SLAS, to discover how a CompacT SelecT system would help them to achieve reproducible results in their cell-based research and development programmes.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
TAP Biosystems Partners with Life Technologies on Protein Expression Platform
The companies will collaborate to develop a cost-efficient, high throughput protein expression platform.
Tuesday, January 15, 2013
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!